Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients

Experimental Dermatology
Laurence DoelkerJann Lübbe

Abstract

Ultraviolet (UV)-induced pyrimidine dimers are an early step in skin carcinogenesis, which is accelerated in the setting of long-term immunosuppression with systemic calcineurin inhibitors. It is not known whether topical application of calcineurin inhibitors exposes to a similar risk. To assess the formation and clearance of UV-induced dipyrimidine dimers in human epidermis treated with topical pimecrolimus as compared to topical steroid, vehicle and untreated control. Pretreated buttock skin of 20 human volunteers with (10) or without (10) atopic dermatitis was exposed to two minimal erythema doses (MED) of simulated solar radiation. DNA was extracted from epidermis 1 and 24 h postirradiation. Pyrimidine dimers were visualized by immuno slot blots and quantified by chemoluminescence image analysis. One-hour postirradiation, pimecrolimus-treated epidermis contains less DNA damage as compared to untreated control, but there were no statistically significant differences between pimecrolimus, triamcinolone acetonide and vehicle. Dimer levels at 24 h postirradiation showed no significant differences between different treatments. Treatment with pimecrolimus cream, triamcinolone acetonide cream and vehicle is not associated with inc...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R W HartA D Woodhead
Sep 1, 1981·The Journal of Investigative Dermatology·S M D'AmbrosioE Lowney
Jun 1, 1996·The Journal of Investigative Dermatology·A R YoungC S Potten
Nov 14, 1997·Trends in Genetics : TIG·D E Brash
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·M S EllerB A Gilchrest
Sep 18, 1998·The Journal of Investigative Dermatology·S ReitamoA I Lauerma
Nov 5, 1998·The Journal of Allergy and Clinical Immunology·T Bieber
Oct 22, 2002·The Journal of Laboratory and Clinical Medicine·Michal HermanUzi Gafter
Nov 20, 2002·Archives of Dermatology·Mona Al MahroosBarbara A Gilchrest
Apr 25, 2003·The New England Journal of Medicine·Sylvie EuvrardAlain Claudy
Aug 28, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·A K Gupta, M Chow
Sep 16, 2003·Journal of Immunological Methods·Marcus S CookeJoseph Lunec
Nov 25, 2004·Experimental Dermatology·M GrassbergerT A Luger
Nov 16, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Christian TranJean-Hilaire Saurat
Nov 22, 2005·The Journal of Investigative Dermatology·Daniel B YaroshDavid A Brown

❮ Previous
Next ❯

Citations

Apr 27, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·David J MargolisWarren Bilker
Nov 3, 2009·Paediatric Drugs·Lily P H Yang, Monique P Curran
Nov 12, 2010·American Journal of Clinical Dermatology·Manjunatha Kalavala, Magdalene A Dohil
Jul 24, 2013·Expert Opinion on Drug Metabolism & Toxicology·Hanna PruchaClaudia Traidl-Hoffmann
Jan 30, 2008·Journal of Dermatological Science·Thilo GambichlerAlexander Kreuter
Aug 5, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas Werfel
Apr 18, 2007·Experimental Dermatology·Maren WeischerMark Berneburg
Nov 14, 2008·Expert Opinion on Pharmacotherapy·Jan EhrchenMartin Steinhoff
Jul 31, 2007·Expert Opinion on Pharmacotherapy·Chrysovalantis KorfitisDimitris Rigopoulos
Oct 6, 2006·Expert Opinion on Pharmacotherapy·Uwe WollinaMohamed Badawy Abdel-Naser
Aug 10, 2011·Journal of Immunological Methods·Onno ten BergeHuib van Weelden
Mar 21, 2017·Dermatologic Clinics·Thierry Passeron
Feb 28, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Johannes RingVerena Henkel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.